Inclisiran adjuvant therapy to statins for the use of hypercholesterolemia: a commentary.
Laiba Imran VohraKashf RizwanEmaan SaeedMuhammad Syed Ali HamzaSidhant OchaniPublished in: The Egyptian heart journal : (EHJ) : official bulletin of the Egyptian Society of Cardiology (2023)
Inclisiran may be utilized alone or in conjunction with other lipid-lowering treatments in individuals who are unable to take statins or for whom they are contraindicated. Furthermore, its exceptional stability throughout a broad range of heat conditions makes its use well-suited for developing countries.